Vaccines

It is well accepted that vaccine development needs to move faster, but how can companies balance compliance and speed?

How is the business of making medicine changing in light of the COVID-19 pandemic?

Supply chains are under strain, but we must all continue to do our part.

The Global Vaccine Summit raised funds to improve international immunization programs.

Llama antibodies may be crucial in the fight against COVID-19.

Your roundup of the key scientific studies and industry announcements emerging from the pandemic.

A new vaccine protects against type 1 diabetes in animal models.

How is the business of making medicine changing in light of the COVID-19 pandemic?

Manufacturers have a unique opportunity to take advantage of the cost and time advantages associated with Oligo(dT) – the adoption process is simple.

When developing countermeasures against COVID-19, resource-poor settings should not be forgotten.